Top 5 Takeaways Variability in Case Definitions: The report highlights the significant variation in toxoplasmosis case definitions across six states, affecting disease estimates and comparisons. Challenges in Surveillance: Identifying newly
Category: MMWR Booster
Top 5 Takeaways High Prevalence of Mental Health Conditions: Among 26,069 surveyed STLT public health workers in 2022, notable percentages reported symptoms of depression (27.7%), anxiety (27.9%), PTSD (28.4%), and
Top 5 Takeaways Vaccine Effectiveness (VE) varies with dose number and Omicron sublineage. VE was generally lower during the Omicron BA.2/BA.2.12.1 period compared to the BA.1 period. A third dose
Top 5 Takeaways Reduction in Adverse Reactions: Among adults aged ≥50 years, adverse reactions were less frequent following a second mRNA COVID-19 booster dose compared to the first booster dose.
Top 5 Takeaways Five measles cases in unvaccinated children: Occurred in children aged 1–9 years living in the same apartment building in Cook County, Illinois, highlighting measles’ high contagion among
Top 5 Takeaways Significant Legionella Impact: Legionella was the predominant cause of reported drinking water outbreaks, accounting for 86% of biofilm-associated outbreaks, highlighting a growing concern over its presence in
Top 5 Takeaways Continued incidence but decreasing trend of MIS-C: While the incidence of Multisystem Inflammatory Syndrome in Children (MIS-C) has decreased significantly from its peak early in the COVID-19
Top 5 Takeaways Identification of Outbreak Source: Morel mushrooms were identified as the likely source of a gastrointestinal illness outbreak in Montana, emphasizing the importance of proper mushroom preparation. Case-Control
Top 5 Takeaways Decreased adverse reactions after second booster: Among individuals ≥50 years who received homologous mRNA COVID-19 vaccination, both injection site and systemic reactions were reported less frequently after
Top 5 Takeaways Outbreak Identification: Between April 12 and May 24, 2022, 23 previously healthy infants aged 5 days to 3 months were admitted with human parechovirus (PeV) meningoencephalitis to